| HCM | hypertrophic cardiomyopathy |
| CMI | cardiac myosin inhibitors |
| LVOT | left ventricular outflow tract |
| oHCM | obstructive hypertrophic cardiomyopathy |
| nHCM | non-obstructive hypertrophic cardiomyopathy |
| ATP | adenosine triphosphate |
| LVEF | left ventricular ejection fraction |
| NYHA | New York Heart Association |
| ECG | electrocardiography |
| KCCQ-CSS | Kansas City Cardiomyopathy Questionnaire Clinical Summary Score |
| HCMSQ-SoB | Hypertrophic Cardiomyopathy Symptom Questionnaire Shortness-of-Breath sub-score |
| HFpEF | heart failure with preserved ejection fraction |
| FDA | Food and Drug Administration |
| EMA | European Medicines Agency |